Study on hGM-CSF modified human hepatoma and gastrocarcinoma cells

Chinese Journal of Microbiology and Immunology

Volumn 17, Issue 3, 1997, Pages 218-221

  Wang, Liqun ^a   Zheng, Zhongcheng ^a   Chen, Shishu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gene therapy; hGM CSF; Immunogenicity; Liver neoplasms therapy; Stomach neoplasms therapy

Indexed keywords

EID: 0346539674     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Porgador A, Feldman M, Eisenbach L. Immunotherapy of tumor metastasis. Via Gene Therapy Nature Immunity, 1994, 13 : 113.
2. Dranoff G, Taffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete mGN-CSF stimulats potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Scei USA, 1993, 90 : 3539.
3. Sanda M, Ayyagri S, Elizabeth J, et al. Demonstration of a retional strategy for human prostate cancer gene therapy. The journal of Virology, 1994, 151 : 622.
4. Simons JW. Gene therapy for human prostate cancer. Cancer, 1995, 75(7) : 2013.
5. Wallach D, Fellows M, Revel M. Prefertial effect of interferon on synthesis of HLA antigen and their mRNAs in human cells. Nature, 1982, 299 : 833.
6. Rosa F, Hatat D, Abadie A, et al. Differential regulation of HLA-DR mRNAs and cell surface antigen by interferon. EMBO J, 1983, 2 : 1585.
7. Simon JW. Phase I study of non-replicating autologous tumor cell infections using cells prepared with or without hGM-CSF gene transduction in patients with metastatic renal cell carcinoma. Human Gene Therapy, 1995, 6 : 347.